Scotland

• 

SMC approves belzutifan for VHL kidney cancer in Scotland

By Sharon Deveson Kell|2023-10-17T15:33:14+00:009 Oct 2023|Drug treatments|

We are delighted to announce that the Scottish Medicines Consortium [...]

Read More

Comments Off on SMC approves belzutifan for VHL kidney cancer in Scotland

• 

Scottish Government’s new 10-year cancer strategy

By Sharon Deveson Kell|2022-06-08T07:26:10+00:008 Jun 2022|Cancer news, Patient advocacy|

Action Kidney Cancer have responded to the Scottish Government's consultation [...]

Read More

Comments Off on Scottish Government’s new 10-year cancer strategy

• 

Scotland’s plan to remobilise and redesign cancer services

By Sharon Kell|2020-08-21T16:31:06+00:0021 Aug 2020|Uncategorized|

The Government in Scotland has published a new plan to [...]

Read More

Comments Off on Scotland’s plan to remobilise and redesign cancer services

• 

First-line cabozantinib declined for a second time for use within NHS Scotland

By Sharon Kell|2019-02-12T08:27:05+00:0012 Feb 2019|Uncategorized|

Cabozantinib has been declined for a second time by the [...]

Read More

Comments Off on First-line cabozantinib declined for a second time for use within NHS Scotland

• 

Cabozantinib declined for use within NHS Scotland for first-line treatment of advanced kidney cancer

By Sharon Kell|2018-10-09T14:26:41+00:009 Oct 2018|Drug treatments|

We are very disappointed by the Scottish Medicines Consortium's (SMC) [...]

Read More

Comments Off on Cabozantinib declined for use within NHS Scotland for first-line treatment of advanced kidney cancer

• 

First-line tivozanib approved for use in NHS Scotland

By Sharon Kell|2018-07-10T14:53:06+00:0010 Jul 2018|Drug treatments|

We are delighted that the Scottish Medicines Consortium (SMC), which reviews [...]

Read More

Comments Off on First-line tivozanib approved for use in NHS Scotland

• 

Nivolumab and cabozantinib accepted for use within NHS Scotland for advanced kidney cancer

By Sharon Kell|2017-06-12T16:09:09+00:0012 Jun 2017|Drug treatments|

The Scottish Medicines Consortium (SMC), which reviews newly licensed medicines, [...]

Read More

Comments Off on Nivolumab and cabozantinib accepted for use within NHS Scotland for advanced kidney cancer

How Scotland plans to improve access to drugs for very rare diseases

By Sharon Kell|2017-01-03T09:56:58+00:003 Jan 2017|Cancer news|

The Scottish government has announced a set of measures aimed [...]

Read More

Comments Off on How Scotland plans to improve access to drugs for very rare diseases